Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hee-Cheol Kim

Showing results (251-260 of 331) with videos related to

Pageof 34
Sort By:
Oncology Reports|May 23, 2012
CC chemokine ligand 7 expression in liver metastasis of colorectal cancerYong Beom Cho, Woo Yong Lee, So-Jung Choi, et al.
International Journal of Colorectal Disease|August 1, 2020
Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection marginJong Yun Baek, Jeong Il Yu, Hee Chul Park, et al.
BMC Cancer|March 23, 2013
Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiationChung Hyun Tae, Kyung Ju Ryu, Seok-Hyung Kim, et al.
Journal of Cosmetic Science|October 10, 2019
Comparative Assessment of Biological Activities of Mistletoes for Cosmetic Applications: <i>Viscum Album Var. Coloratum (Kom.) Ohwi</i> and <i>Loranthus Tanakae Franch. & Sav.</i>Sung-Up Choi, Sung Tae Kim, Dong Gyun Han, et al.
Tumori|August 18, 2018
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapyTae Gyu Kim, Won Park, Hakyoung Kim, et al.
Journal of Nanoscience and Nanotechnology|October 27, 2018
Preparation of Silica Microparticles as Volatile Material Carrier and Their Sustained-Release PropertyYeong-Seo Do, Kwan Hyung Cho, Hee-Cheol Kim, et al.
Oncology|March 14, 2015
Is Chemoradiotherapy Beneficial for Stage IV Rectal Cancer?Jung Wook Huh, Hee Cheol Kim, Hee Chul Park, et al.
Annals of Surgery|November 8, 2017
Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal CancerJae Hyuck Jang, Hee Cheol Kim, Jung Wook Huh, et al.
BMC Cancer|August 11, 2011
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapyByung-Hoon Min, Jeong Mo Bae, Eui Jin Lee, et al.
Radiation Oncology Journal|July 4, 2019
Risk factors for locoregional recurrence in patients with pathologic T3N0 rectal cancer with negative resection margin treated by surgery aloneJong Yun Baek, Jeong Il Yu, Hee Chul Park, et al.
Pageof 34

Showing results (251-260 of 331) with videos related to

Sort By:
Pageof 34
Oncology Reports|May 23, 2012
CC chemokine ligand 7 expression in liver metastasis of colorectal cancerYong Beom Cho, Woo Yong Lee, So-Jung Choi, et al.
International Journal of Colorectal Disease|August 1, 2020
Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection marginJong Yun Baek, Jeong Il Yu, Hee Chul Park, et al.
BMC Cancer|March 23, 2013
Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiationChung Hyun Tae, Kyung Ju Ryu, Seok-Hyung Kim, et al.
Journal of Cosmetic Science|October 10, 2019
Comparative Assessment of Biological Activities of Mistletoes for Cosmetic Applications: <i>Viscum Album Var. Coloratum (Kom.) Ohwi</i> and <i>Loranthus Tanakae Franch. & Sav.</i>Sung-Up Choi, Sung Tae Kim, Dong Gyun Han, et al.
Tumori|August 18, 2018
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapyTae Gyu Kim, Won Park, Hakyoung Kim, et al.
Journal of Nanoscience and Nanotechnology|October 27, 2018
Preparation of Silica Microparticles as Volatile Material Carrier and Their Sustained-Release PropertyYeong-Seo Do, Kwan Hyung Cho, Hee-Cheol Kim, et al.
Oncology|March 14, 2015
Is Chemoradiotherapy Beneficial for Stage IV Rectal Cancer?Jung Wook Huh, Hee Cheol Kim, Hee Chul Park, et al.
Annals of Surgery|November 8, 2017
Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal CancerJae Hyuck Jang, Hee Cheol Kim, Jung Wook Huh, et al.
BMC Cancer|August 11, 2011
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapyByung-Hoon Min, Jeong Mo Bae, Eui Jin Lee, et al.
Radiation Oncology Journal|July 4, 2019
Risk factors for locoregional recurrence in patients with pathologic T3N0 rectal cancer with negative resection margin treated by surgery aloneJong Yun Baek, Jeong Il Yu, Hee Chul Park, et al.
Pageof 34